Apyx Medical (APYX) Stock: Buy, Sell, or Hold?
APYX - Apyx Medical Corporation Common Stock
$2.37
-0.04 (-1.66%)
▼
5d:
-7.06%
30d:
-16.25%
90d:
-39.07%
HOLD
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 05, 2026
12d
Get Alerted When APYX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: APYX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: APYX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: APYX is currently trading at $2.37, which is considered oversold relative to its 30-day fair value range of $2.44 to $2.89.
Technical Outlook: Technically, APYX is in a strong downtrend. Immediate support is located at $2.25, while resistance sits at $2.73.
Market Sentiment: APYX scores 72/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $6.50 (+174.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, APYX is in a strong downtrend. Immediate support is located at $2.25, while resistance sits at $2.73.
Market Sentiment: APYX scores 72/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $6.50 (+174.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.44 -
$2.89
Company Quality Score
56/100
(HOLD)
Options IV Signal
34th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
89.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 34th percentile)
- BULLISH: Strong technical setup (72/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 174.3% below Wall St target ($6.50)
- BULLISH: Bottoming setup score 72/100 — corrected, stabilizing, and turning up
- CAUTION: Recommendation downgraded due to -7.1% 5-day decline
Trading Range Analysis
30-Day Trading Range
$2.44 -
$2.89
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.37
(15.7%)
Support & Resistance Levels
Support Level
$2.25
Resistance Level
$2.73
Current Trend
Strong Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.42
Wall Street Target
$6.50
(+174.3%)
Revenue Growth (YoY)
22.1%
Profit Margin
-14.8%
Share & Embed Analysis
Last updated: October 23, 2026 5:11 PM ET
Data refreshes hourly during market hours. Next update: 6:11 PM
Data refreshes hourly during market hours. Next update: 6:11 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APYX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 46 HOLD |
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 41 HOLD |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 38 SELL |
|
AXGN
Axogen Inc |
STRONG BUY
12 analysts |
$54 | 70 BUY |
|
PODD
Insulet Corporation |
BUY
26 analysts |
$167 | 37 SELL |
